Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea

BACKGROUND: To validate the clinical application of chromosomal microarray analysis (CMA) as a first-tier clinical diagnostic test and to determine the impact of CMA results on patient clinical management, we conducted a multicenter prospective study in Korean patients diagnosed as having developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Woori, Kim, Yonggoo, Han, Eunhee, Park, Joonhong, Chae, Hyojin, Kwon, Ahlm, Choi, Hayoung, Kim, Jiyeon, Son, Jung-Ok, Lee, Sang-Jee, Hong, Bo Young, Jang, Dae-Hyun, Han, Ji Yoon, Lee, Jung Hyun, Kim, So Young, Lee, In Goo, Sung, In Kyung, Moon, Yeonsook, Kim, Myungshin, Park, Joo Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340852/
https://www.ncbi.nlm.nih.gov/pubmed/30623622
http://dx.doi.org/10.3343/alm.2019.39.3.299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340852/
https://www.ncbi.nlm.nih.gov/pubmed/30623622
http://dx.doi.org/10.3343/alm.2019.39.3.299

Ejemplares similares